Prot# M03-601: Evaluation of the Safety, Tolerability and Pharmacokinetic Profiles of Single Rising Doses and Increasing Administration Rates of Intravenous ABT-870 in ESRD Subjects on Chronic Hemodialysis with Iron Deficiency Anemia

Project: Research project

Project Details

StatusFinished
Effective start/end date7/13/041/13/06

Funding

  • Paragon Biomedical, Inc. (M03-601)
  • Abbott Laboratories (M03-601)